58 related articles for article (PubMed ID: 6161700)
1. Coronary artery disease after treatment with bleomycin and vinblastine.
Vogelzang NJ; Frenning DH; Kennedy BJ
Cancer Treat Rep; 1980; 64(10-11):1159-60. PubMed ID: 6161700
[No Abstract] [Full Text] [Related]
2. Long-term treatment with cis-dichlorodiammineplatinum(II)-vinblastine-bleomycin: possible association with severe coronary artery disease.
Edwards GS; Lane M; Smith FE
Cancer Treat Rep; 1979 Apr; 63(4):551-2. PubMed ID: 87274
[No Abstract] [Full Text] [Related]
3. Fatal coronary artery fibrosis after treatment with bleomycin, vinblastine, and cis-platinum.
Bodensteiner DC
South Med J; 1981 Jul; 74(7):898-9. PubMed ID: 6166992
[No Abstract] [Full Text] [Related]
4. Bleomycin-vinblastine associated Raynaud's phenomenon.
Paty JG; Ruffner BW
J Rheumatol; 1980; 7(6):927-8. PubMed ID: 6162955
[No Abstract] [Full Text] [Related]
5. [Complications of chemotherapy protocols combining cis-platinum, vinblastine and bleomycin].
Unger PF; Praloran V; Tobelem G; Jacquillat C
Nouv Presse Med; 1981 Feb; 10(9):713. PubMed ID: 6163131
[No Abstract] [Full Text] [Related]
6. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
[No Abstract] [Full Text] [Related]
7. Longitudinal studies of nutritional status in patients having chemotherapy for testicular teratomas.
Atukorala TM; Dickerson JW; Basu TK; McElwain TJ
Clin Oncol; 1983 Mar; 9(1):3-10. PubMed ID: 6189659
[TBL] [Abstract][Full Text] [Related]
8. [Coronary disease and vinorelbine].
Ruffenach M; Missler J; Meier M; Salen JM
Rev Pneumol Clin; 1994; 50(2):94. PubMed ID: 7839061
[No Abstract] [Full Text] [Related]
9. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Williamson PJ; de Berker D
Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
[No Abstract] [Full Text] [Related]
10. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
11. The absence of influence of acetylsalicylic acid (ASA) on the transient decrease in platelet counts observed after infusion of bleomycin and vinblastine.
Verweij J; Kester DM; Breed WP; Hillen HF; Pinedo HM
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1471-4. PubMed ID: 2420602
[TBL] [Abstract][Full Text] [Related]
12. Raynaud's phenomenon with vinblastine and bleomycin.
Harvey HA; Lipton A; Lawrence BV
Ann Intern Med; 1981 Apr; 94(4 pt 1):542-3. PubMed ID: 6163385
[No Abstract] [Full Text] [Related]
13. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
Dunlop PR; Hendy-Ibbs PM
Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
[No Abstract] [Full Text] [Related]
14. Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma.
Young DC; Mitchell A; Kessler J; Christman JE
J Am Osteopath Assoc; 1993 Apr; 93(4):502-4, 507. PubMed ID: 7683015
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin-induced hyperpigmentation and hypersensitivity reactions to etoposide and vinblastine in a child with endodermal sinus tumor.
Mutafoğlu-Uysal K; Sarialioğlu F; Olgun N
Turk J Pediatr; 2001; 43(2):172-4. PubMed ID: 11432501
[TBL] [Abstract][Full Text] [Related]
16. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Canellos GP; Duggan D; Johnson J; Niedzwiecki D
J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
[No Abstract] [Full Text] [Related]
17. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.
Bodrogi I; Baki M; Hindy I; Eckhardt S
Neoplasma; 1983; 30(5):557-61. PubMed ID: 6197662
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Kelsen DP; Bains M; Chapman R; Golbey R
Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
[TBL] [Abstract][Full Text] [Related]
20. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
